COVID-19 Products Had Strong 2021, But Omicron Casts Shadow Over 2022

Windfall From Drugs, Vaccines Sparks Talk Of Merger Mania

 
• By Alaric DeArment

Evidence that the new variant dulls drugs and vaccines’ efficacy creates uncertainty for 2022, but new products are in the wings.

COVID globe
How the drug and vaccine market developed in 2021, and how Omicron hangs over 2022 • Source: Shutterstock

More from COVID-19

More from Scrip